Ebselen

This classification denotes a cyclooxygenase inhibitor and antioxidant with the molecular formula C13H9NOSe, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40X2P7DPGH, chemically known as 1,2-benzisoselenazol-3(2h)-one, 2-phenyl- but generally known as ebselen, which bears US NIH Compound Identifier 3194. European Medicines Agency schedules Ebselen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06439MIG. The term EBSELEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). EBSELEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ebselen under HS 29349990 and SITC 51579. As of Q4 2014, EBSELEN remains the US FDA Preferred Term for this commodity. Ebselen bears US NLM identifiers UMLS ID C0058903 and NCI Concept Code C65503. SMILES: [SE]1N(C(=O)C2C1CCCC2)C1CCCCC1.